The association of genetic variants of type 2 diabetes with kidney function

Kidney International

Volumn 82, Issue 2, 2012, Pages 220-225

  Franceschini, Nora ^a   Shara, Nawar M ^b,c   Wang, Hong ^b   Saroja Voruganti, V ^d   Laston, Sandy ^d   Haack, Karin ^d   Lee, Elisa T ^e   Best, Lyle G ^f   MacCluer, Jean W ^d   Cochran, Barbara J ^g   Dyer, Thomas D ^d   Howard, Barbara V ^b,c   Cole, Shelley A ^d   North, Kari E ^a,h   Umans, Jason G ^b,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

^c Delaware   (United States)

^d SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f MISSOURI BREAKS INDUSTRIES RESEARCH INC   (United States)

^g UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^h Carolina Center for Genome Sciences   (United States)

Author keywords

albuminuria; diabetes; kidney function; SNPs

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; FTO GENE; GENE; GENE DOSAGE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLOMERULUS FILTRATION RATE; HUMAN; KCNJ11 GENE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PRIORITY JOURNAL; RENAL SYSTEM PARAMETERS; SINGLE NUCLEOTIDE POLYMORPHISM; TCF7L2 GENE; URINE ALBUMIN TO CREATININE RATIO; WFS1 GENE;

EID: 84863303697     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.107     Document Type: Article

References (54)

1. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134-2140.
2. Lucove J, Vupputuri S, Heiss G et al. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis 2008; 51: 21-28.
3. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001; 59: 260-269.
4. Fagot-Campagna A, Nelson RG, Knowler WC et al. Plasma lipoproteins and the incidence of abnormal excretion of albumin in diabetic American Indians: the Strong Heart Study. Diabetologia 1998; 41: 1002-1009.
5. Gambaro G, Verlato F, Budakovic A et al. Renal impairment in chronic cigarette smokers. J Am Soc Nephrol 1998; 9: 562-567.
6. Pinto-Sietsma SJ, Mulder J, Janssen WM et al. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000; 133: 585-591.
7. Robbins DC, Knowler WC, Lee ET et al. Regional differences in albuminuria among American Indians: an epidemic of renal disease. Kidney Int 1996; 49: 557-563.
8. Scavini M, Stidley CA, Paine SS et al. The burden of chronic kidney disease among the Zuni Indians: the Zuni kidney project. Clin J Am Soc Nephrol 2007; 2: 509-516.
9. Luo F, Wang Y, Wang X et al. A functional variant of NEDD4L is associated with hypertension, antihypertensive response, and orthostatic hypotension. Hypertension 2009; 54: 796-801.
10. Shara NM, Resnick HE, Lu L et al. Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident CVD: the Strong Heart Study. J Nephrol 2009; 22: 373-380.
11. Shara NM, Wang H, Valaitis E et al. Comparison of estimated glomerular filtration rates and albuminuria in predicting risk of coronary heart disease in a population with high prevalence of diabetes mellitus and renal disease. Am J Cardiol 2011; 107: 399-405.
12. US renal data system: excerpts from the USRDS 2006 annual data report. Am J Kidney Dis 2006; 49(suppl 291): S1-S296.
13. Silveiro SP, Friedman R, de Azevedo MJ et al. Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients. Diabetes Care 1996; 19: 171-174.
14. Pruijm M, Wuerzner G, Maillard M et al. Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region. Nephrol Dial Transplant 2010; 25: 2225-2231.
15. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 1996; 49: 1774-1777.
16. Kramer HJ, Nguyen QD, Curhan G et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003; 289: 3273-3277.
17. Franceschini N, Voruganti VS, Haack K et al. The association of the MYH9 gene and kidney outcomes in American Indians: the strong heart family study. Hum Genet 2010; 127: 295-301.
18. Kim NH, Pavkov ME, Knowler WC et al. Predictive value of albuminuria in American Indian youth with or without type 2 diabetes. Pediatrics 2010; 125: e844-e851.
19. Bleyer AJ, Sedor JR, Freedman BI et al. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease. Am J Kidney Dis 2008; 51: 29-37.
20. Imperatore G, Knowler WC, Nelson RG et al. Genetics of diabetic nephropathy in the Pima Indians. Curr Diab Rep 2001; 1: 275-281.
21. MacCluer JW, Scavini M, Shah VO et al. Heritability of measures of kidney disease among Zuni Indians: the Zuni kidney project. Am J Kidney Dis 2010; 56: 289-302.
22. Mottl AK, Vupputuri S, Cole SA et al. Linkage analysis of albuminuria. J Am Soc Nephrol 2009; 20: 1597-1606.
23. Mottl AK, Vupputuri S, Cole SA et al. Linkage analysis of glomerular filtration rate in American Indians. Kidney Int 2008; 74: 1185-1191.
24. Wolfs MG, Hofker MH, Wijmenga C et al. Type 2 diabetes mellitus: new genetic insights will lead to new therapeutics. Curr Genomics 2009; 10: 110-118.
25. Liu L, Zheng T, Wang F et al. Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Care 2010; 33: 144-149.
26. Ohshige T, Tanaka Y, Araki S et al. A single nucleotide polymorphism in KCNQ1 is associated with susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabetes Care 2010; 33: 842-846.
27. Buraczynska M, Swatowski A, Markowska-Gosik D et al. Transcription factor 7-like 2 (TCF7L2) gene polymorphism and complication/comorbidity profile in type 2 diabetes patients. Diabetes Res Clin Pract 2011; 93: 390-395.
28. Kottgen A, Hwang SJ, Rampersaud E et al. TCF7L2 variants associate with CKD progression and renal function in population-based cohorts. J Am Soc Nephrol 2008; 19: 1989-1999.
29. Matise TC, Ambite J, Buyske S et al. Population architecture using genetics and epidemiology. Am J Epidemiol 2011; 174: 849-859.
30. Howard BV, Lee ET, Cowan LD et al. Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study. Am J Epidemiol 1995; 142: 254-268.
31. Takeda K, Inoue H, Tanizawa Y et al. WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet 2001; 10: 477-484.
32. Ueda K, Kawano J, Takeda K et al. Endoplasmic reticulum stress induces Wfs1 gene expression in pancreatic beta-cells via transcriptional activation. Eur J Endocrinol 2005; 153: 167-176.
33. Knowler WC, Pettitt DJ, Saad MF et al. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990; 6: 1-27.
34. Frayling TM, Timpson NJ, Weedon MN et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889-894.
35. Elks CE, Loos RJ, Sharp SJ et al. Genetic markers of adult obesity risk are associated with greater early infancy weight gain and growth. PLoS Med 2010; 7: e1000284.
36. Hubacek JA, Viklicky O, Dlouha D et al. The FTO gene polymorphism is associated with end-stage renal disease: two large independent casecontrol studies in a general population. Nephrol Dial Transplant 2012; 27: 1030-1035.
37. Zeggini E, Weedon MN, Lindgren CM et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007; 316: 1336-1341.
38. Omori S, Tanaka Y, Takahashi A et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 2008; 57: 791-795.
39. Wang F, Han XY, Ren Q et al. Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population. Chin Med J (Engl) 2009; 122: 2477-2482.
40. Nielsen EM, Hansen L, Carstensen B et al. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 2003; 52: 573-577.
41. Yang L, Zhou X, Luo Y et al. Association between KCNJ11 gene polymorphisms and risk of type 2 diabetes mellitus in East Asian populations: a meta-analysis in 42,573 individuals. Mol Biol Rep 2012; 39: 645-659.
42. Hsu CY, McCulloch CE, Iribarren C et al. Body mass index and risk for endstage renal disease. Ann Intern Med 2006; 144: 21-28.
43. Grant SF, Thorleifsson G, Reynisdottir I et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006; 38: 320-323.
44. Palmer ND, Hester JM, An SS et al. Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant. Diabetes 2011; 60: 662-668.
45. Pearson ER. Translating TCF7L2: from gene to function. Diabetologia 2009; 52: 1227-1230.
46. Lancaster MA, Gleeson JG. Cystic kidney disease: the role of Wnt signaling. Trends Mol Med 2010; 16: 349-360.
47. Lee ET, Welty TK, Fabsitz R et al. The Strong Heart Study. a study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 1990; 132: 1141-1155.
48. North KE, Howard BV, Welty TK et al. Genetic and environmental contributions to cardiovascular disease risk in American Indians: the Strong Heart Family Study. Am J Epidemiol 2003; 157: 303-314.
49. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
50. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
51. Boerwinkle E, Chakraborty R, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann Hum Genet 1986; 50: 181-194.
52. Havill LM, Dyer TD, Richardson DK et al. The quantitative trait linkage disequilibrium test: a more powerful alternative to the quantitative transmission disequilibrium test for use in the absence of population stratification. BMC Genet 2005; 6(Suppl 1): S91.
53. Ioannidis JP, Patsopoulos NA, Evangelou E. Heterogeneity in metaanalyses of genome-wide association investigations. PLoS One 2007; 2: e841.
54. Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557-560.